These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16892030)

  • 1. ALS: life and death in a bad neighborhood.
    Monk PN; Shaw PJ
    Nat Med; 2006 Aug; 12(8):885-7. PubMed ID: 16892030
    [No Abstract]   [Full Text] [Related]  

  • 2. Onset and progression in inherited ALS determined by motor neurons and microglia.
    Boillée S; Yamanaka K; Lobsiger CS; Copeland NG; Jenkins NA; Kassiotis G; Kollias G; Cleveland DW
    Science; 2006 Jun; 312(5778):1389-92. PubMed ID: 16741123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant mice, Cu,Zn superoxide dismutase, and motor neuron degeneration.
    McCord JM
    Science; 1994 Dec; 266(5190):1586-7. PubMed ID: 7985031
    [No Abstract]   [Full Text] [Related]  

  • 4. [ALS and microglia--a player for non-cell-autonomous neuron death].
    Yamanaka K; Yamashita H
    Brain Nerve; 2007 Oct; 59(10):1163-70. PubMed ID: 17969357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyotrophic lateral sclerosis--are microglia killing motor neurons?
    Borchelt DR
    N Engl J Med; 2006 Oct; 355(15):1611-3. PubMed ID: 17035656
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin suppresses symptom onset and progression of G93A-SOD1 mouse model of ALS by preventing motor neuron death and inflammation.
    Koh SH; Kim Y; Kim HY; Cho GW; Kim KS; Kim SH
    Eur J Neurosci; 2007 Apr; 25(7):1923-30. PubMed ID: 17439481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading.
    Subramaniam JR; Lyons WE; Liu J; Bartnikas TB; Rothstein J; Price DL; Cleveland DW; Gitlin JD; Wong PC
    Nat Neurosci; 2002 Apr; 5(4):301-7. PubMed ID: 11889469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cytotoxic potential of microglia from ALS-transgenic mice.
    Weydt P; Yuen EC; Ransom BR; Möller T
    Glia; 2004 Nov; 48(2):179-82. PubMed ID: 15378658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic and molecular mechanisms of motor neuron disease.
    Wong PC; Rothstein JD; Price DL
    Curr Opin Neurobiol; 1998 Dec; 8(6):791-9. PubMed ID: 9914243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of microglial neuregulin1 signaling in the corticospinal tracts of ALS patients with upper motor neuron signs.
    Song F; Chiang P; Ravits J; Loeb JA
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):77-83. PubMed ID: 24229388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
    Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
    Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.
    Morrison BM; Morrison JH; Gordon JW
    J Exp Zool; 1998 Sep-Oct 1; 282(1-2):32-47. PubMed ID: 9723164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathoetiology of motor neuron disease: new insights from genetics and animal models.
    Trounce I; Feeney S; Byrne E
    J Clin Neurosci; 2003 May; 10(3):293-6. PubMed ID: 12763330
    [No Abstract]   [Full Text] [Related]  

  • 15. Increase of disease duration of amyotrophic lateral sclerosis in a mouse model by transgenic small interfering RNA.
    Yokota T; Sasaguri H; Saito Y; Yamada H; Unno T; Yamamoto Y; Kubodera T; Anzai M; Mitani T; Mizusawa H
    Arch Neurol; 2007 Jan; 64(1):145-6. PubMed ID: 17210827
    [No Abstract]   [Full Text] [Related]  

  • 16. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapeutic targets in neurodegenerative diseases: lessons from amyotrophic lateral sclerosis.
    Appel SH; Beers DR; Henkel JS; Zhao W
    Curr Neurol Neurosci Rep; 2008 Sep; 8(5):353-5. PubMed ID: 18713569
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
    Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
    Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).
    Howland DS; Liu J; She Y; Goad B; Maragakis NJ; Kim B; Erickson J; Kulik J; DeVito L; Psaltis G; DeGennaro LJ; Cleveland DW; Rothstein JD
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1604-9. PubMed ID: 11818550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Of mice, men and motor neurons.
    Newbery HJ; Abbott CM
    Trends Genet; 2001 Oct; 17(10):S2-6. PubMed ID: 11585669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.